Intersect ENT: Real-world Data Support Use Of PROPEL In Patients Undergoing Endoscopic Sinus Surgery
(RTTNews) - Intersect ENT, Inc. (XENT) reported positive results of an observational, cohort study using real-world evidence data from adult patients with chronic rhinosinusitis with or without nasal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results